MohanadMohammedAl-ObaidiMDMPH, FIDSA

Infectious Disease • Tucson, AZ

Transplant/Immunocompromised States

Clinical associate professor

Join to view full profile

Dr. Al-Obaidi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Al-Obaidi's full profile

Already have an account?

Office
1501 N Campbell Ave
Tucson, AZ 85724
Phone+1 520-694-0111

Fax+1 520-694-4085

Summary

Dr. Mohanad Al-Obaidi is an infectious disease specialist in Tucson, AZ and is affiliated with multiple hospitals in the area, including Banner - University Medical Center Tucson and Banner - University Medical Center South. He received his medical degree from Other and has been in practice 9 years. He specializes in transplant/immunocompromised states.

Education & Training

University of ArizonaMPH, 2021, 2019 - 2021
University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 2015 - 2018
Texas Tech University (Amarillo)Residency, Internal Medicine, 2012 - 2015
University of Baghdad College of MedicineClass of 2008

Certifications & Licensure

AZ State Medical License 2018 - 2027
TX State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole Start of enrollment: 2022 Aug 03
Suspended
Phase 3

Publications & Presentations

PubMed

The performance of bronchoalveolar lavage Aspergillus PCR testing in solid organ transplant recipients with invasive pulmonary aspergillosis.
Sibel Islak Mutcali, Nadeem Hussain, Saman Nematollahi, William Lainhart, Tirdad T Zangeneh
Transplant Infectious Disease. 2024-10-01
Clinical Characteristics and Mortality Risks Among Patients With Culture-Proven Coccidioidomycosis Who Are Critically Ill: A Multicenter Study in an Endemic Region.
James Lim, Ashley M Scott, Rebecca Wig, Rachel V Tan, Emily R Harnois
Open Forum Infectious Diseases. 2024-08-01
Hypoalbuminemia and Posaconazole Therapeutic Drug Monitoring.
David E Nix, Mohanad Al-Obaidi, Tirdad Zangeneh
Open Forum Infectious Diseases. 2024-08-01

Journal Articles

The Reply.
Al-Obaidi MM, Tanriover B, Zangeneh TT., American Journal of Medicine, 2/1/2024
Diagnostic Challenges of Coccidioidomycosis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
Mohanad Al-Obaidi, Tirdad Zangeneh, Curr Fungal Infect Rep, 1/25/2023

Press Mentions

Preparing for the Respiratory Illness Season: Key Insights on RSV, Flu and COVID-19November 25th, 2024

Professional Memberships

IDSA
Member